ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
Resting tremor | 17.01.06.008 | 0.000009% | | Not Available |
Drug-induced liver injury | 12.03.01.044; 09.01.07.023 | 0.000076% | | Not Available |
Substance-induced psychotic disorder | 19.03.01.007; 12.03.01.053 | 0.000113% | | Not Available |
Peripheral artery thrombosis | 24.01.02.010 | 0.000018% | | Not Available |
Granulomatosis with polyangiitis | 24.12.04.011; 22.01.01.015; 20.05.01.013; 10.02.02.018 | 0.000022% | | Not Available |
Intraductal proliferative breast lesion | 16.10.01.006; 21.05.01.014 | 0.000009% | | Not Available |
Reversible cerebral vasoconstriction syndrome | 24.04.06.026; 18.06.01.004; 17.08.02.014 | 0.000009% | | Not Available |
Drug reaction with eosinophilia and systemic symptoms | 12.03.01.064; 23.03.05.005; 10.01.01.021 | 0.000090% | | Not Available |
Autoimmune haemolytic anaemia | 01.06.01.004; 10.04.01.005 | 0.000040% | | Not Available |
Faeces soft | 07.01.03.008 | 0.000022% | | Not Available |
Noninfective gingivitis | 07.09.13.016 | - | - | Not Available |
Peripheral venous disease | 24.04.02.022 | 0.000009% | | Not Available |
Mouth swelling | 23.04.01.020; 10.01.05.020; 07.05.04.007 | - | - | Not Available |
Respiratory symptom | 22.12.02.013 | - | - | Not Available |
Sinus node dysfunction | 02.03.03.017 | 0.000018% | | |
Perforation | 08.01.03.058 | - | - | Not Available |
Stenosis | 08.01.03.060 | - | - | Not Available |
Multiple organ dysfunction syndrome | 08.01.03.057 | 0.000282% | | |
Anal incontinence | 17.05.01.021; 07.01.06.029 | 0.000018% | | |
Frustration tolerance decreased | 19.04.02.016 | 0.000013% | | Not Available |
Adverse food reaction | 08.06.01.025 | - | - | Not Available |
Abdominal mass | 07.01.01.003 | - | - | Not Available |
Abnormal loss of weight | 14.03.02.019 | 0.000009% | | Not Available |
Acute myelomonocytic leukaemia | 01.10.05.005; 16.01.05.005 | 0.000009% | | Not Available |
Adenocarcinoma of colon | 16.13.01.010; 07.21.01.008 | 0.000036% | | Not Available |
Behcet's syndrome | 23.06.02.004; 21.10.03.009; 15.01.01.009; 10.02.02.015; 07.05.06.008; 06.04.05.017; 24.12.04.003 | 0.000013% | | Not Available |
Bone cancer | 16.29.02.002; 15.09.03.012 | - | - | Not Available |
Brain neoplasm malignant | 17.20.04.002; 16.30.04.002 | - | - | Not Available |
Breast cancer in situ | 21.05.01.015; 16.10.01.007 | 0.000009% | | Not Available |
Central nervous system lymphoma | 18.04.04.013; 17.02.10.028; 16.20.01.005; 01.12.01.005 | 0.000018% | | Not Available |